ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]
Category Archives: Press Release
21
Sep
Sep
Largest clinical dataset of its kind driving diagnosis and discovery worldwide GAITHERSBURG, MD, Sept. 21, 2021 – GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset […]
Press Release
Sports Tech Company, Orreco and Scarlet Health team up to provide a new solution for Athletes to optimize performance
01
Sep
Sep
Los Angeles CA – (Sep 1, 2021) Specialist sports performance and biomarker company Orreco have joined forces with Scarlet Health, an on-demand diagnostic service by BioReference Laboratories Inc., an OPKO Health company (NASDAQ:OPK), providing a superior, fully integrated digital solution that addresses modern testing needs, to provide a new solution for pre-season athlete physicals and in-season […]
Press Release
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
26
Aug
Aug
New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Press Release
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
16
Aug
Aug
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
22
Jun
Jun
MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers. Under the agreement, unvaccinated guests will be required to undergo rapid, point-of-care PCR COVID-19 prior to embarking. These guests will […]
Press Release
Major League Soccer Renews BioReference Laboratories as COVID-19 Testing Provider for Second Year
27
Apr
Apr
BioReference continues providing PCR molecular and rapid COVID-19 testing to Major League Soccer players, match officials, and Club and League employees BioReference is testing New England Revolution Fans for COVID-19 at Gillette Stadium in Foxborough, Massachusetts ELMWOOD PARK, N.J., April 27, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as […]
Press Release
BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
01
Apr
Apr
ELMWOOD PARK, N.J., April 1, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball (MLB) season. Under the agreement with MLB, BioReference will provide on-site rapid PCR point-of-care COVID-19 testing to all […]
SPOKANE, Wash., March 30, 2021 /PRNewswire/ — Gestalt Diagnostics today announced, that BioReference Laboratories Inc., an OPKO Health company, has selected their digital pathology solution, PathFlow®, to support its pathology business. PathFlow is an enterprise software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories. Under the agreement, Gestalt is partnering […]
BioReference is currently testing students and staff from two of the five largest school districts in the nation and is prepared to rapidly expand COVID-19 school testing to other school districts across the country ELMWOOD PARK, N.J., March 26, 2021 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the expansion of its COVID-19 school […]